Zdrowie i gospodarka · 13/07/2012

FDA Withdraws Chloramphenicol Capsules from Sale Due to Safety Concerns

The US Food and Drug Administration (FDA) has made the decision to remove chloramphenicol capsules, 250 milligrams, from the market due to concerns over their safety and effectiveness, and will not consider any new applications for these products.